glp-1 agonists examples Diabetes Patients Also Struggle to Access Holding GLP-1 Agonists Prior to

Zhao S, Yan Z, Du Y, Li Z, Tang C, Jing L, et al

Most available GLP-1 RAs are given as subcutaneous injections

I have tried these drugs they are not worth the price

As these drugs are used inappropriately for vanity reasons, plan sponsors are considering cost, value, and risks - i.e., thinking twice about coverage and the cost-benefit

Furthermore, non-users of GLP-1RAs exhibited more than a twofold higher risk of all-cause mortality compared with GLP-1RA users ( 5.1 Systemic and hepatic efficacy: Correcting metabolic derangements and steatosis As depicted in Figure 1, GLP-1 RAs are highly effective at correcting the core metabolic derangements seen in MASLD/T2DM